EMMA ESPINEL: Open Payments
NPI 1609483486 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,219 in 46 payments from 25 companies in 2025. Trend: 2023 $60 · 2024 $1,684 · 2025 $1,219
Food & beverage: $1,062Education: $158
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 7 | $164 |
| Aveo Pharmaceuticals, Inc. | 2 | $96 |
| Celgene Corporation | 4 | $89 |
| AstraZeneca Pharmaceuticals LP | 4 | $85 |
| SOBI, INC | 3 | $78 |
| Janssen Biotech, Inc. | 1 | $78 |
| Johnson & Johnson Health Care Systems Inc. | 1 | $69 |
| Eisai Inc. | 3 | $67 |
| Daiichi Sankyo Inc. | 2 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
Products named: FOTIVDA, BOSULIF, REBLOZYL, ERLEADA, ELREXFIO, TECVAYLI, Lenvima, Doptelet.
Industry payments across AZ — which companies pay providers there.
